Privia Health Group (PRVA) closed at $24.54 on November 9, 2026, up 0.5% from the previous close, on volume of 1,603,529 shares (30-day average 1,280,261).
Data as of November 9, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 20, 2026 | Call Spread | 20-Nov-2620 : 22.5 C | 500 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Privia Health Group (PRVA) Gets a Buy from Piper Sandler
TipRanks (Fri, 6-Nov 9:17 AM ET)
Privia Health Earnings Call Signals Strong Growth Ahead
TipRanks (Thu, 5-Nov 7:12 PM ET)
Evercore ISI Sticks to Their Buy Rating for Privia Health Group (PRVA)
TipRanks (Thu, 5-Nov 5:37 PM ET)
Privia Health Group reports mixed Q3 results; raises FY26 outlook
Seeking Alpha News (Thu, 5-Nov 6:25 AM ET)
Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results
Globe Newswire (Thu, 5-Nov 6:00 AM ET)
Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business
Globe Newswire (Mon, 2-Nov 8:30 AM ET)
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
Globe Newswire (Thu, 8-Oct 9:00 AM ET)
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
Globe Newswire (Tue, 18-Aug 9:00 AM ET)
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Privia Health Group trades on the NASDAQ stock market under the symbol PRVA.
As of November 9, 2026, PRVA stock price climbed to $24.54 with 1,603,529 million shares trading.
PRVA has a beta of 0.24, meaning it tends to be less sensitive to market movements. PRVA has a correlation of 0.01 to the broad based SPY ETF.
PRVA has a market cap of $3.13 billion. This is considered a Mid Cap stock.
Last quarter Privia Health Group reported $657 million in Revenue and $.21 earnings per share. This beat revenue expectation by $49 million and met earnings estimates .
In the last 3 years, PRVA traded as high as $28.82 and as low as $15.92.
The top ETF exchange traded funds that PRVA belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
PRVA has underperformed the market in the last year with a return of +2.3%, while SPY returned +13.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PRVA shares. However, PRVA has outperformed the market in the last 3 month and 2 week periods, returning +11.5% and +9.5%, while SPY returned -1.8% and -1.0%, respectively. This indicates PRVA has been having a stronger performance recently.
PRVA support price is $23.96 and resistance is $24.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRVA shares will trade within this expected range on the day.
